Collectively, we discovered miR-206 targets 3′-UTR of c-Met and Bcl2 mRNA, and inhibits the expression of c-Met and Bcl2 in lung cancer cell lines (A549 and SK-MES-1). Here, MET is linked to lung carcinoma.